Rangering i aksjer
#41014
PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery... PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery platform technology, having successfully transitioned into the commercial stage. The company's primary offerings include Vazalore 325 mg, which is formulated for individuals facing vascular incidents like heart attacks and clot-induced strokes, as well as for the management of pain and inflammation. Additionally, they provide Vazalore 81 mg in the form of liquid-filled aspirin capsules. Looking ahead, their product development pipeline features PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, both of which are in Phase I clinical trials for addressing pain, inflammation, and fever. PLx Pharma makes its products available to consumers through a variety of retail avenues, including pharmacies, major retailers, supermarkets, and online sales channels. Founded in 2002, PLx Pharma Inc. is headquartered in Sparta, New Jersey.
Aksjekurs
$0.00575
Sist synkronisert: 2023-05-23
Handel PLx Pharma Inc. (PLXP)
Pris PLXP pris med markedsverdi på B
Markedsverdi av PLx Pharma Inc.(PLXP)
Markedsverdi: $51.30K
Per August 2026 har PLx Pharma Inc. en markedsverdi på $51.30K. Dette gjør PLx Pharma Inc. til det 41014th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for PLx Pharma Inc. fra 2014 til 2026
PLXP sammenlignet med topp 5 mest populære stocks
| Pris på PLXP |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.470T
|
+10,662,337,937.50%
|
|
|
|
|
$4.467T
|
+8,708,125,730.73%
|
|
|
|
|
$4.174T
|
+8,137,564,781.05%
|
|
|
|
|
$3.700T
|
+7,212,944,876.35%
|
|
|
|
|
$2.854T
|
+5,564,266,566.07%
|
